STERIS’ (TSE:STE – Get Free Report) was upgraded by analysts at Cormark to a “moderate buy” rating in a research report issued to clients and investors on Monday,Zacks.com reports.
Separately, Atb Cap Markets upgraded shares of STERIS’ to a “strong-buy” rating in a research report on Sunday, December 22nd.
Get Our Latest Research Report on STERIS’
STERIS’ Stock Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Stories
- Five stocks we like better than STERIS’
- Profitably Trade Stocks at 52-Week Highs
- Top 2 Auto Maintenance Stocks Gearing Up for 2025
- 3 Healthcare Dividend Stocks to Buy
- 100% Upside? Amprius Technologies Is Charged for Growth in 2025
- What Investors Need to Know to Beat the Market
- The 5 Stocks Congress Bought Most in 2024: Top Picks for 2025
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
